Patent Infringement Litigation

Related by string. patent infringement litigation * Patents . patents . patenting : patent infringement suit . Patent Portfolio . patent pending invisibleSHIELD / infringements . Infringements . INFRINGEMENT : patent infringement lawsuit . patent infringement lawsuits / litigations . LITIGATION : Securities Litigation Reform Act . Private Securities Litigation Reform * *

Related by context. Frequent words. (Click for all words.) 79 Patent Dispute 75 Patent Suit 74 Patent Infringement 74 Files Patent 70 Achieves Milestone 70 Patient Enrollment 69 Generic Version 69 Receives Patent 69 Q2 Loss Narrows 68 FDA Accepts 68 Antitrust Case 68 Q1 Loss Widens 68 Patent Litigation 68 Drug Candidate 68 FDA Clears 68 Develop Next Generation 68 Extends Tender Offer 67 Receives Positive 67 Extends Offer 67 Awarded Patent 67 Provides Guidance 67 Completes Enrollment 67 Acquire Assets 67 Q3 Loss Widens 67 Complete Merger 67 Cholesterol Drug 67 Q3 Loss Narrows 67 Q2 Loss Widens 67 Regains Compliance 67 Q1 Loss Narrows 66 Share Repurchases 66 Jury Verdict 66 Annual Meeting Date 66 Signs Licensing Agreement 66 Announces Definitive Agreement 66 Q4 Loss Narrows 66 Q4 Loss Widens 66 Announces Initiation 66 Receives FDA Clearance 65 Share Buyback 65 Updates Guidance 65 Clinical Trial Results 65 Narrows Loss 65 Trademark Infringement 65 Shares Soar 65 Exclusive License 65 Stock Buyback 64 Introduces Next Generation 64 Significantly Reduces 64 Previously Announced 64 Discontinues 64 Q4 Profit Surges 64 Expand Relationship 64 Licensing Deal 64 Revenues Decline 64 Updates Shareholders 64 False Advertising 64 Net Loss Narrows 64 Announces Successful Completion 64 Provides Preliminary 64 Waiting Period 64 Presents Positive 64 Multimillion Dollar 64 Momentum Continues 64 Announces Issuance 64 Shareholder Investigation 64 Secures Additional 64 Shareholder Vote 63 Cervical Cancer Vaccine 63 Shareholders Approve Merger 63 Spins Off 63 Lowers Guidance 63 Reduces Risk 63 Action Lawsuits 63 Cuts Costs 63 Delist 63 Extends Leadership 63 Files Annual Report 63 Completes Private Placement 63 Low Dose 63 Successful Completion 63 Shelf Registration Statement 63 Issues Guidance 63 Forecast Quick Facts 63 1Q Profit Falls 63 Phase III Trial 63 Begins Shipping 63 Preclinical Data 63 Unveils Next Generation 63 Receives Notice 63 Notice Regarding 63 Update# 62 Action Suit 62 Issues Statement Regarding 62 Secures Funding 62 Phase III Clinical Trial 62 Finalizes Acquisition 62 Shows Promise 62 Updates Status 62 Smallpox Vaccine 62 Above Estimates

Back to home page